StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx gross margin

Gross margin is gross profit as a percentage of revenue.

BioCorRx's gross margin for the twelve months ending Jun 30, 2025 was 100.0%. For fiscal 2024 it was 78.3%, against 59.6% the year before. The highest annual figure on record is 92.9% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202478.3%+18.6
FY2023Dec 31, 202359.6%−33.2
FY2022Dec 31, 202292.9%+5.0
FY2021Dec 31, 202187.8%+66.1
FY2020Dec 31, 202021.8%−44.3
FY2019Dec 31, 201966.0%+11.4
FY2018Dec 31, 201854.6%+3.8
FY2017Dec 31, 201750.8%−24.2
FY2016Dec 31, 201675.0%−8.6
FY2015Dec 31, 201583.6%+2.4
FY2014Dec 31, 201481.1%+3.5
FY2013Dec 31, 201377.6%+24.0
FY2012Dec 31, 201253.6%+5.5
FY2011Dec 31, 201148.1%+56.3
FY2010Dec 31, 2010-8.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-64.8%−164.8
Q1 FY2026Mar 31, 202688.3%+34.3
Q2 FY2025Jun 30, 2025100.0%+68.9
Q1 FY2025Mar 31, 2025100.0%+38.3
Q2 FY2024Jun 30, 2024100.0%+52.8
Q1 FY2024Mar 31, 202454.0%−24.6
Q4 FY2023Dec 31, 202331.1%−61.4
Q3 FY2023Sep 30, 202361.7%−26.8
Q2 FY2023Jun 30, 202347.2%−46.6
Q1 FY2023Mar 31, 202378.5%+108.8
Q1 FY2022Mar 31, 202292.5%+48.0
Q2 FY2021Sep 30, 202188.5%+70.2
Q1 FY2021Mar 31, 202193.8%+55.9
Q4 FY2020Dec 31, 2020-30.3%−88.4
Q3 FY2020Sep 30, 202044.5%−7.6
Q2 FY2020Jun 30, 202018.4%−35.6
Q1 FY2020Mar 31, 202037.8%−57.8
Q4 FY2019Dec 31, 201958.1%+83.0
Q3 FY2019Sep 30, 201952.1%−21.7
Q2 FY2019Jun 30, 201954.0%+7.7
Q1 FY2019Mar 31, 201995.7%+17.9
Q4 FY2018Dec 31, 2018-25.0%−48.8
Q3 FY2018Sep 30, 201873.8%−20.8
Q2 FY2018Jun 30, 201846.3%+25.5
Q1 FY2018Mar 31, 201877.8%−4.8
Q4 FY2017Dec 31, 201723.8%−32.0
Q3 FY2017Sep 30, 201794.6%+17.1
Q2 FY2017Jun 30, 201720.8%−54.6
Q1 FY2017Mar 31, 201782.6%+0.2
Q4 FY2016Dec 31, 201655.9%−26.9
Q3 FY2016Sep 30, 201677.5%–
Q2 FY2016Jun 30, 201675.4%–
Q1 FY2016Mar 31, 201682.4%–
Q4 FY2015Dec 31, 201582.8%–

More BioCorRx figures

See a number that looks wrong?